Latest filings (excl ownership)
424B3
Prospectus supplement
13 Dec 10
EFFECT
Notice of effectiveness
10 Dec 10
UPLOAD
Letter from SEC
30 Nov 10
D
$400M in debt / Subsidiary Guarantees, sold $400M, 5 investors
6 Oct 10
8-K
Inverness Medical Innovations, Inc. Extends Exchange Offer for 7.875% Senior Notes due 2016
25 May 10
424B3
Prospectus supplement
23 Apr 10
EFFECT
Notice of effectiveness
21 Apr 10
POSASR
Automatic shelf registration (post-effective amendment)
29 Mar 10
S-4
Registration of securities issued in business combination transactions
12 Feb 10
D
$100M in debt / Subsidiary Guarantees, sold $100M, 3 investors
13 Oct 09
424B5
Prospectus supplement for primary offering
6 Aug 09
424B5
Prospectus supplement for primary offering
4 Aug 09
POSASR
Automatic shelf registration (post-effective amendment)
4 Aug 09
8-A12B
Registration of securities on exchange
12 May 09
424B5
Prospectus supplement for primary offering
8 May 09
424B5
Prospectus supplement for primary offering
4 May 09
S-3ASR
Automatic shelf registration
10 Apr 09
REGDEX
Notice of sale of securities
22 Jun 05
REGDEX
Notice of sale of securities
17 Mar 03
REGDEX
Notice of sale of securities
26 Mar 02
REGDEX/A
Notice of sale of securities (amended)
12 Mar 02
REGDEX
Notice of sale of securities
29 Jan 02
Latest ownership filings
No filings